Every prescription is a clinical trial

Systematic review combined with a double blind evaluation has not supported it as an evidence based treatment, 3 yet individual patients are reported as deriving notable benefit, which, in this typical case was 18 months' pain relief after two treatments. 4 As it remains, however, a useful and...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 329; no. 7478; p. 1346
Main Author Lake, Alfred P J
Format Journal Article
LanguageEnglish
Published England British Medical Association 04.12.2004
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Systematic review combined with a double blind evaluation has not supported it as an evidence based treatment, 3 yet individual patients are reported as deriving notable benefit, which, in this typical case was 18 months' pain relief after two treatments. 4 As it remains, however, a useful and valued component of the planned staged approach to the management of chronic regional pain syndrome type 1, many pain clinicians will continue to include it or an equivalent intervention in their armamentarium. 5 An additional problem that regularly occurs is the removal from the market of valuable drugs (although often for limited indications) which are effective in, and appropriate for, many individual patients.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
Competing interests: None declared.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.329.7478.1346